University Of North Carolina At Chapel Hill is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Location | Chapel Hill, NC, USA |
|---|---|
| Type | Public Research University |
| Founded | 1789 |
| Website | [unc.edu](https://www.unc.edu) |
The University of North Carolina at Chapel Hill (UNC) is the flagship public research university of the UNC System and the oldest public university in the United States, founded in 1789. UNC Chapel Hill is home to world-class research programs in neuroscience and neurodegeneration, particularly through the UNC School of Medicine and the UNC Neuroscience Center.
The UNC Neuroscience Center is one of the nation's leading neuroscience research institutes, housing over 150 faculty members working on:
The Bryan ADRC, funded by the NIA, focuses on:
A multidisciplinary initiative bringing together:
| Disease Area | Research Focus |
|---|---|
| Alzheimer's Disease | Amyloid and tau biology, biomarkers, clinical trials, health disparities |
| Parkinson's Disease | Alpha-synuclein, LRRK2, deep brain stimulation |
| ALS | SOD1, C9orf72, TDP-43, therapeutic screening |
| Multiple Sclerosis | Myelin biology, immune modulation, remyelination |
| Huntington's Disease | Genetic modifiers, therapeutic targets |
UNC collaborates with:
The study of University Of North Carolina At Chapel Hill has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Rebeck GW, et al. (1995). "Structure and function of apolipoprotein E in the brain." Progress in Lipid Research. PMID:7655167.
Cohen TJ, et al. (2013). "The microtubule-associated tau protein in Alzheimer's disease." Nature Reviews Neuroscience. PMID:24215764.
Petersen RC, et al. (2019). "Mild cognitive impairment: clinical characterization and outcome." Annals of Neurology. PMID:30848251.